Hemostats Market Size & Share, by Application (Trauma, Cardiovascular Surgery, Orthopedic Surgery, Plastic Surgery, Neurosurgery, General Surgery); Product (Active, Passive, Combination); End-user (Hospital, Casualty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4484
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Hemostats Landscape

top-features-companies
    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Integra LifeSciences Corporation
    • Baxter AG
    • Medtronic plc
    • Stryker Inc.
    • BD (Becton, Dickinson, and Company)
    • Biom’up Innovative Surgery
    • Johnson & Johnson Services, Inc.
    • CryoLife, Inc.
    • Hemostatis LLC

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Pfizer Inc. announced the acquisition of Global Blood Therapeutics to amplify the rare hematology and to brace the treatment for sickle cell disease. This agreement was finalized at the worth of USD 5.4 billion.

  • Biom’up announced the approval of Hemosnow by U.S. Food and Drug Administration . Hemosnow is a hemostatic dry powder for control the mild levels of bleeding during surgical procedures.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4484
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising need of blood transfusion, increased cases of cancer, increase in number of hospitals and higher chances of road accidents are the few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Lack of trained professionals, high cost of the product and inability of hemostats to restrict uncontrollable bleeding are the few factors which are likely to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Pfizer Inc., Integra LifeSciences Corporation, Baxter, Medtronic, Stryker, BD (Becton, Dickinson and Company), Biom’up Innovative Surgery, Johnson & Johnson Services, Inc., CryoLife, Inc., Hemostatis LLC and so on…

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product, end user, and by region.

The orthopedic surgery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying